Informazione:
Errore:
ID
34393
Descrizione
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status; ODM derived from: https://clinicaltrials.gov/show/NCT01283386
collegamento
https://clinicaltrials.gov/show/NCT01283386
Keywords
versioni (1)
- 17/01/19 17/01/19 -
Titolare del copyright
GSK group of companies
Caricato su
17 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
- StudyEvent: Eligibility
Similar models
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
adult patients, 60-70 or >70 years of age
boolean
ID.2
Item
cumulative illness rating scale (cirs) comorbidity score >/=7 if patient is 60-70 years old
boolean
ID.3
Item
previously untreated b-cell chronic lymphocytic leukemia
boolean
ID.4
Item
binet stage b, c or a with progression
boolean
ID.5
Item
ecog performance status 0-2
boolean
ID.6
Item
small-cell lymphoma
boolean
ID.7
Item
autoimmune hemolytic anemia
boolean
ID.8
Item
concomitant malignant disease during enrollment, except for basal cell carcinoma of the skin
boolean
ID.9
Item
chemotherapy for concomitant malignant disease within 12 months prior to study enrollment
boolean
ID.10
Item
richter's syndrome
boolean